We are live on
!
Find out more
EARNEST Partners Portfolio holdings
AUM
$24.3B
1-Year Est. Return
34.41%
This Fund
S&P 500
This Quarter
Est. Return
+7.57%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$10B
AUM Growth
+$518M
(+5.4%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
18.87%
Holding
233
New
8
Increased
78
Reduced
133
Closed
4
Top Buys
| 1 |
Darling Ingredients
DAR
|
+$67.4M |
| 2 |
EastGroup Properties
EGP
|
+$40.3M |
| 3 |
PENN Entertainment
PENN
|
+$33.5M |
| 4 |
Arrow Electronics
ARW
|
+$32M |
| 5 |
Avnet
AVT
|
+$17.4M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
+$99.4M |
| 2 |
TSMC
TSM
|
+$29.1M |
| 3 |
FPO
First Potomac Realty Trust
FPO
|
+$24.9M |
| 4 |
Icon
ICLR
|
+$16.9M |
| 5 |
VWR
VWR Corporation
VWR
|
+$15.7M |
Sector Composition
| 1 | Financials | 21.08% |
| 2 | Industrials | 18.89% |
| 3 | Technology | 13.56% |
| 4 | Healthcare | 13.03% |
| 5 | Consumer Discretionary | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Dover
DOV
$29.1B
| $21.7M | 0.22% |
293,312
-7,070
| -2% | -$491K |
|
127
Walt Disney
DIS
$170B
| $20.8M | 0.21% |
211,111
-12,999
| -6% | -$1.34M |
|
128
Goldman Sachs
GS
$317B
| $20.8M | 0.21% |
87,726
-5,745
| -6% | -$1.3M |
|
|
STFC
129
DELISTED
State Auto Financial Corp
STFC
| $20.5M | 0.2% |
780,544
+18,219
| +2% | +$453K |
|
130
JPMorgan Chase
JPM
$915B
| $20.2M | 0.2% |
211,468
-14,079
| -6% | -$1.3M |
|
|
ECHO
131
EchoStar
ECHO
$26.7B
| $20.1M | 0.2% |
434,257
-12,126
| -3% | -$578K |
|
132
Union Pacific
UNP
$179B
| $20M | 0.2% |
172,309
-10,358
| -6% | -$1.11M |
|
133
Cencora
COR
$60.7B
| $19M | 0.19% |
229,718
-6,128
| -3% | -$520K |
|
|
XEC
134
DELISTED
CIMAREX ENERGY CO
XEC
| $18.3M | 0.18% |
160,638
-8,211
| -5% | -$819K |
|
|
ARRS
135
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $18.1M | 0.18% |
634,938
-834
| -0.1% | -$23.1K |
|
|
136
Avnet
AVT
$6.91B
| $17.9M | 0.18% |
+454,543
| New | +$17.4M |
|
137
Automatic Data Processing
ADP
$101B
| $16.1M | 0.16% |
147,173
-9,985
| -6% | -$1.07M |
|
138
ON Semiconductor
ON
$33.9B
| $15.6M | 0.16% |
844,317
-9,088
| -1% | -$146K |
|
139
Keysight
KEYS
$53.3B
| $15.5M | 0.15% |
371,293
-12,708
| -3% | -$520K |
|
140
Sonoco
SON
$5.55B
| $15M | 0.15% |
298,083
-3,163
| -1% | -$156K |
|
141
Factset
FDS
$9.12B
| $14.7M | 0.15% |
81,754
-2,456
| -3% | -$401K |
|
|
HTLF
142
DELISTED
Heartland Financial USA, Inc.
HTLF
| $13.4M | 0.13% |
272,154
+23,561
| +9% | +$1.08M |
|
143
Becton Dickinson
BDX
$43.7B
| $13.2M | 0.13% |
68,946
-2,118
| -3% | -$411K |
|
144
Royal Caribbean
RCL
$77.3B
| $13.1M | 0.13% |
110,315
-10,338
| -9% | -$1.21M |
|
145
APA Corp
APA
$12.2B
| $11.2M | 0.11% |
244,620
-14,106
| -5% | -$622K |
|
146
Aflac
AFL
$63.6B
| $11.2M | 0.11% |
274,836
-18,534
| -6% | -$746K |
|
147
Kimberly-Clark
KMB
$36.4B
| $11.1M | 0.11% |
94,480
-6,335
| -6% | -$774K |
|
|
BIG
148
DELISTED
Big Lots, Inc.
BIG
| $10.6M | 0.11% |
197,959
-928
| -0.5% | -$45.7K |
|
149
Petrobras
PBR
$115B
| $10.5M | 0.1% |
1,042,587
-24,081
| -2% | -$219K |
|
150
Southern Company
SO
$109B
| $10.2M | 0.1% |
206,959
-13,245
| -6% | -$642K |
|
Similar funds
JG
SC
CS
AF
EARNEST Partners's Q3 2017 Portfolio in Review
As of Q3 2017, EARNEST Partners held 233 positions worth $10B, up 5.4% from $9.52B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
EARNEST Partners's Q3 2017 filing shows 8 new, 78 increased, 133 reduced and 4 closed positions. Its largest new stake was Darling Ingredients: 3,984,504 shares worth $69.8M. The largest sale was Teva Pharmaceuticals, an estimated $99.4M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.
- EARNEST Partners's largest Q3 2017 buy was Darling Ingredients: 3,984,504 shares worth $69.8M.
- EARNEST Partners added most to Core Laboratories in Q3 2017, an estimated $11.2M increase.
- EARNEST Partners's biggest Q3 2017 reduction was TSMC, cutting an estimated $29.1M.
- EARNEST Partners fully exited Teva Pharmaceuticals in Q3 2017, selling an estimated $99.4M.
- EARNEST Partners's ten largest holdings make up 19% of its $10B portfolio in Q3 2017.
- EARNEST Partners opened 8 new positions and closed 4 in Q3 2017.
- EARNEST Partners's portfolio value rose 5.4% quarter-over-quarter to $10B.
Based on EARNEST Partners's 13F filing for Q3 2017, filed 14 Nov 2017.